Speakers | Intelligent Health AI | 12 October 2021 | Amsterdam & Online

Meet our previous AI healthcare heroes

YAN HUANG
General Manager - Intelligent Healthcare
Baidu
                     
YAN HUANG
General Manager - Intelligent Healthcare
Baidu
                     

Yan has nearly 20 years of experience in the field of machine learning and artificial intelligence, with a focus on R&D, application, management and innovation. She has been the General Manager of Baidu Intelligent Healthcare since 2018. During her role, she has launched the brand “Ling Yi Zhi Hui (Chinese name:灵医智惠) “ with the vision of “Evidence-based AI empowers primary healthcare”.

 

Prior to joining Baidu, she was the Staff R&D engineer at Google in the U.S., where she started her career in 2005.

 

Yan graduated from Georgia Institute of Technology. Yan serves as the Vice Chairman of Intelligent Hospital and Artificial Intelligence Application Working Committee of Chinese Medical Information and big data Association (CHMIA). She also serves as a leading advisory expert of Peking University Medical Science and Technology Innovation Project.

DR. ROBERT CALIFF
Former Commissioner FDA & Head of Health and Policy 
Alphabet (Google Health and Verily Life Sciences)
     
DR. ROBERT CALIFF
Former Commissioner FDA & Head of Health and Policy 
Alphabet (Google Health and Verily Life Sciences)
     
DR. JOHN HALAMKA
President
Mayo Clinic Platform
   
DR. JOHN HALAMKA
President
Mayo Clinic Platform
   
WENJUN XIE
Head of AI Healthcare Strategy
Tencent
       
WENJUN XIE
Head of AI Healthcare Strategy
Tencent
       
DR. PETER LEE
Corporate Vice President, Healthcare
Microsoft
DR. PETER LEE
Corporate Vice President, Healthcare
Microsoft

Dr. Peter Lee is Corporate Vice President, Microsoft Healthcare. He leads an organization that works on technologies for better and more efficient healthcare, with a special focus on artificial intelligence and cloud computing. Dr. Lee has extensive experience in managing the process of going from basic research to commercial impact. Past illustrative examples include the deep neural networks for simultaneous language translation in Skype, next-generation IoT technologies, and innovative silicon and post-silicon computer architectures for Microsoft’s cloud. He also has a history of advancing more “out of the box” technical efforts, such as experimental under-sea datacenters, augmented-reality experiences for HoloLens and VR devices, digital storage in DNA, and social chatbots such as XiaoIce and Tay. Previously, as an Office Director at DARPA, he led efforts that created operational capabilities in advanced machine learning, crowdsourcing, and big-data analytics, such as the DARPA Network Challenge and Nexus 7. He was formerly the Head of Carnegie Mellon University’s computer science department. As a thought leader, he has spoken and written widely on technology trends and policies, spanning the fields of computing technology, healthcare, and innovation ecosystem. He is a member of the Boards of Directors of the Allen Institute for Artificial Intelligence and the Kaiser Permanente School of Medicine. He served on President’s Commission on Enhancing National Cybersecurity. He has led studies for the National Academies on the impact of federal research investments on economic growth and testified before the US House Science and Technology Committee and the US Senate Commerce Committee.

DR. TOBY COSGROVE
Executive Advisor and Former President & CEO
Google & Cleveland Clinic
DR. TOBY COSGROVE
Executive Advisor and Former President & CEO
Google & Cleveland Clinic

Toby Cosgrove, MD, is former CEO and president of Cleveland Clinic. Serving from 2004 through 2017, he led the $8 billion organization to new heights of achievement and efficiency, seeing it ranked the #2 hospital in America (U.S. News). He currently serves as Executive Advisor, working with Cleveland Clinic leadership on strategies for national and international growth.

 

Dr. Cosgrove graduated from Williams College and the University of Virginia School of Medicine. He trained at Massachusetts General Hospital and Brook General Hospital in London. In 1967, he was a surgeon in the U.S. Air Force, earning a Bronze Star.

 

Dr. Cosgrove joined Cleveland Clinic in 1975, and chaired the Department of Thoracic and Cardiovascular surgery from 1989 to 2004. He performed over 22,000 operations and earned an international reputation in valve repair He holds 30 patents for medical innovations. As CEO from 2004 to 2017, he reorganized services, improved outcomes and patient experience, and strengthened the organization’s finances.

 

He is a member of the National Academy of Medicine, and a Fellow of the National Academy of Inventors. In 2016, he was a Fortune Businessperson of the Year (No. 14). Three successive presidents of the United States have consulted him on healthcare issues.

BERNARDO MARIANO JUNIOR
Director, Digital Health & Innovation, Chief Information Officer
World Health Organization
   
BERNARDO MARIANO JUNIOR
Director, Digital Health & Innovation, Chief Information Officer
World Health Organization
   

Bernardo Mariano Junior is the Director of the Digital Health Department and the Chief Information Officer of WHO. He is responsible for setting and maintaining the vision and direction of WHO’s strategy of health in the digital age. As CIO, he ensures that the digital transformation of WHO enhances the organization’s collective performance and efficiency to deliver the ‘Health for all’ global development agenda.

Prior to joining WHO, Mr. Mariano held senior managerial positions in the International Organization for Migration as Senior Regional Adviser for Sub-Saharan Africa in the office of the Director-General, Chief Information Officer/Director, Information & Communications Technology, and Regional Director for East and Southern Africa.

VANESSA CANDEIAS
Former Head, Global Health and Healthcare; Member of the Executive Committee
World Economic Forum
VANESSA CANDEIAS
Former Head, Global Health and Healthcare; Member of the Executive Committee
World Economic Forum

Trained as a nutritionist, Faculty of Nutrition and Food Sciences, Porto University; Master’s in Public Health, London School of Hygiene and Tropical Medicine. Formerly: worked at national level on developing and implementing health promotion policies with the Ministry of Health in Portugal and the Institute of Preventive Medicine of the University of Lisbon; worked with the World Health Organization Headquarters on global guidelines and policy development for noncommunicable diseases.

 

Currently, Head of System Initiative on Shaping the Future of Health and Healthcare and Member of the Executive Committee, World Economic Forum. The System Initiative on Shaping the Future of Health and Healthcare provides a dynamic platform for leading businesses, governments, civil society organizations and world-class experts to shape the global health agenda; co-design and accelerate the implementation of collaborative approaches that transform the health ecosystem – across prevention, diagnosis, treatment, cure and maintenance of health; and ultimately enables populations to live healthier lives and have access to the care they need when they need it.

DR. FREDDY ABNOUSI
Interventional Cardiologist and Head of Health Technology
Facebook
                 
DR. FREDDY ABNOUSI
Interventional Cardiologist and Head of Health Technology
Facebook
                 

Dr. Abnousi is the Head of Health Technology at Facebook and a practicing Interventional Cardiologist. He also serves as Innovation Advisor to the American College of Cardiology, Professor Adjunct at Stanford University School of Medicine, and Assistant Professor Adjunct at Yale University School of Medicine. He has previously led innovative healthcare efforts at companies such as McKinsey and Google, and has served as Founder and CMO of CorDynamix Inc., an interventional heart failure company. He completed Fellowships in Cardiovascular Medicine and Interventional Cardiology, as well as Residency in Internal Medicine at Stanford University Medical Center. He was previously a resident surgeon at the University of California, San Francisco. He completed his MD at Stanford University School of Medicine, MBA from Oxford University, and MSc in Health Policy, Planning, & Financing from the London School of Economics. 

KIMBERLY POWELL
Vice President Healthcare
NVIDIA
KIMBERLY POWELL
Vice President Healthcare
NVIDIA

Kimberly Powell is vice president of healthcare at NVIDIA, where she leads the company’s efforts to build healthcare computing platforms that address grand challenges like early detection, diagnoses and personalized treatment.

Partnering with healthcare researchers, startups and industry leaders, her mission is to accelerate the adoption of advanced computing technologies like GPU computing and artificial intelligence.

Powell joined NVIDIA in 2008 as the global business development manager for healthcare. She also served as senior director of AI business development. Prior to joining NVIDIA, she was a product manager for diagnostic imaging at Planar Systems and a hardware engineer at DOME Imaging Systems doing FPGA design.

Powell has a Bachelor of Science from Northeastern University in electrical engineering with a concentration in computer engineering.

JOHN NOSTA
President
NostaLab
         
JOHN NOSTA
President
NostaLab
         

First and foremost, John is a thinker. A thinker entrenched in the world of science, medicine and innovation. John is the founder of NOSTALAB—a digital health think tank. He’s generally regarded as one of the top global strategic and creative thinkers in this important and expanding area. He is also one the most popular speakers around the globe presenting his vibrant and insightful perspective on the future of health innovation.

Unwilling to accept the status quo, he’s a contrarian with a focus the future of health and wellness. A leading voice in the convergence of technology and health, Nosta helps define, dissect and deliberate global trends in digital health. He is consistently ranked among the top names in almost every digital list and has sustained that position for several years. Beyond simply an influencer, John is also defined as “most admired” to “top disruptor” in digital health, life sciences and the pharmaceutical industry. He is also a member of the Google Health Advisory Board and has penned HEALTH CRITICAL for Forbes–a top global blog on health and technology.

John has an established reputation as a vocal advocate for strategic thinking and creativity. He has built his career on the “science of advertising,” a process where strategy and creativity work together for superior marketing. He has also been recognized for his ability to translate difficult medical and scientific concepts into material that can be more easily communicated to consumers, clinicians and scientists. Additionally, John has distinguished himself as a scientific thinker. Earlier in his career, John was a research associate at Harvard Medical School and has co-authored several papers with global thought-leaders in the field of cardiovascular physiology with a focus on acute myocardial infarction, ventricular arrhythmias and sudden cardiac death.

John cut his teeth at the “big” agencies including Ogilvy CommonHealth, where he has held a series of positions including Chief Creative Officer, Chief Strategic Officer and unit President.

 

DR. GREG MOORE
Corporate Vice President 
Microsoft Health
             
DR. GREG MOORE
Corporate Vice President 
Microsoft Health
             

Dr. Moore leads Microsoft’s Health efforts globally and is responsible for product strategy, product development, and research including AI and machine learning technology for healthcare and life sciences. He is also Microsoft’s senior executive leading dedicated research and development collaborations with Microsoft’s strategic alliance partners in this domain with the goal of enabling a more open, interoperable, and AI-infused foundation for healthcare delivery that aspires to enable access to healthcare for all globally.

Greg is an engineer (MIT PhD), practicing neuroradiologist, clinical informaticist, neuroscientist, and innovator experienced in assembling and inspiring highly talented teams to positively transform healthcare for the benefit of humankind. Prior to joining Microsoft, Greg was Vice President Google Inc, Google Cloud Healthcare & Life Sciences and founder of the healthcare vertical for Google Cloud. Prior to his leadership appointment at Google, he was Chief Emerging Technology and Informatics Officer at Geisinger Health System where he also was Director of the Institute for Advanced Application and served as Interim Chair of System Radiology. His prior appointments include Los Alamos National Laboratory (University of California), Wayne State University School of Medicine, Children’s Hospital of Michigan and Penn State University Hershey Medical Center where he was a tenured Professor in the College of Medicine. Greg currently serves on the board Hillrom Inc, and is an Adjunct Clinical Professor of Radiology at Stanford University School of Medicine.

Moore is board certified in Diagnostic Radiology, Neuroradiology and Clinical Informatics and holds degrees from North Park College-Chicago (BS), Massachusetts Institute of Technology (SM-Nuclear Engineering and PhD-Radiological Sciences), and Wayne State University School of Medicine (MD-Doctor of Medicine) and completed residency in Diagnostic Radiology and a fellowship in Neuroradiology, both at Penn State University Hershey Medical Center.

 

ANN AERTS
Head
Novartis Foundation
         
ANN AERTS
Head
Novartis Foundation
         

The Novartis Foundation focuses on innovating health and care for low-income populations, driven by data, digital and AI. Ann chairs the Broadband Commission for Sustainable Development Working Group on Digital Health, is a member of the International Advisory Board of the Commonwealth Centre for Digital Health. Ann served as a member of the US National Academies of Science Engineering and Medicine Committee on Improving the Quality of Health Care Globally and currently sits on the US National Academies of Medicine Commission on Healthy Longevity.

 

Before leading the Novartis Foundation, Ann was Franchise Medical Director Critical Care for Novartis Pharma in Basel and Therapeutic Area Head Cardiovascular and Metabolism for Novartis Pharma Belgium. 

Prior to joining Novartis, she served as Director of the Lung and Tuberculosis Association in Belgium and as Head of the Health Services Department of the International Committee of the Red Cross (ICRC) in Geneva. She has also worked as Health Coordinator for the ICRC in several countries.

 

Ann holds a Degree in Medicine and a Masters in Public Health from the University of Leuven, Belgium, as well as a Degree in Tropical Medicine from the Institute of Tropical Medicine in Antwerp, Belgium. 

 

BAKUL PATEL
Associate Centre Director for Digital Health
FDA
BAKUL PATEL
Associate Centre Director for Digital Health
FDA

Bakul Patel is Associate Director for Digital Health, at the Center for Devices and Radiological Health (CDRH), at the Food and Drug Administration (FDA).  Mr. Patel leads regulatory policy and scientific efforts at the Center in areas related to emerging and converging areas of medical devices, wireless and information technology. This includes responsibilities for mobile health, health information technology, cyber security, medical device interoperability, and medical device software. 
 

Mr. Patel is the FDA liaison between the Federal Communications Commission (FCC) and the Office of the National Coordinator (ONC). Since its inception in 2013, Bakul chairs the International Medical Device Regulators Forum (IMDRF) “software as a medical device” working group, a global harmonization effort.

Before joining FDA, Mr. Patel held key leadership positions working in the telecommunications industry, semiconductor capital equipment industry, wireless industry and information technology industry. His experience includes Lean Six Sigma, creating long and short-term strategy, influencing organizational change, modernizing government systems, and delivering high technology products and services in fastpaced, technology-intensive organizations.
 

Mr. Patel earned an MS in Electronic Systems Engineering from the University of Regina, Canada, and an MBA in International Business from The Johns Hopkins University.

DR. SEMA SGAIER
Co-Founder & Executive Director | Surgo Foundation
Adjunct Assistant |Harvard TH Chan School of Public Health 
DR. SEMA SGAIER
Co-Founder & Executive Director | Surgo Foundation
Adjunct Assistant |Harvard TH Chan School of Public Health 

Dr. Sema Sgaier leads Surgo Foundation’s strategy, operations, and partner relations. She works at the intersection of behavior, data, and technology, drawing on her extensive experience in policy, strategy, and management of development programs.  Sema has led several large-scale programs, as well as research and evaluation projects, and has worked with governments in India and Africa on public-health policy and large-scale delivery. 

Prior to joining Surgo Foundation, Sema held several roles at the Bill & Melinda Gates Foundation. She led a portfolio on voluntary medical male circumcision for HIV prevention across eastern and southern Africa. As part of the India Country Office, Sema led the scale-up of the foundation’s HIV prevention program (Avahan) in several states, managed its transition to the government of India, and developed data platforms for decision-making. 

Before joining the Gates Foundation, Sema was a neuroscience and genomics scholar at Harvard Medical School and a fellow with the Centre for Global Health Research. She is an Assistant Adjunct Professor at the Harvard T.H. Chan School of Public Health and an Affiliate Assistant Professor, Global Health at the University of Washington. She also serves on the board of the Bill & Melinda Gates Foundation’s Alumni Network. Sema was selected as a Rising Talent by the Women’s Forum for the Economy and Society.  

Sema received her PhD in cellular and molecular biology (developmental genetics) from New York University, her MA in neuroscience from Brown University, and a BSc in molecular biology and genetics from Boğaziçi University (Istanbul).   

 

MARK O'HERLIHY
Managing Director EMEA
IBM Watson Health
MARK O'HERLIHY
Managing Director EMEA
IBM Watson Health

Head of IBM Watson Health for Europe, Middle East & Africa. As the Managing Director, Mark holds full responsibility for the Sales & Go to Market strategy & team, for Watson Health software products and solutions to their customers. This includes the full portfolio of Life Sciences, Oncology, Genomics, Imaging, Government, Value-Based Care & Population Health Management solutions.

 

Mark has a clinical background and has worked in the NHS as well as many senior leadership positions in global, European and start-up healthcare companies throughout his career, with over 25 years of experience in the healthcare segment, Mark brings a wealth of experience and perspective and he is passionate about health and social care for everyone.

PROF. GARY MARCUS
Professor of Psychology and Neural Science
New York University
PROF. GARY MARCUS
Professor of Psychology and Neural Science
New York University

Gary Marcus, scientist, bestselling author, and entrepreneur, was CEO and Founder of the machine-learning startup Geometric Intelligence, recently acquired by Uber, and is known for his provocative and bold claims in artificial intelligence, neuroscience, and cognitive science. Trained by Steven Pinker, he received his PhD at MIT at age 23. His professional research, published in leading journals such as Science, Nature, Cognition, and Artificial Intelligence, has focused on the foundations of cognition in humans, animals and machines, spanning fields from developmental psychology to neuroscience to genetics to artificial intelligence. A special interest has been on the challenge of endowing machines with common sense.

 

He is also well-known for his writing for the general public, including frequent essays and op-eds for The New Yorker and The New York Times. His books include The Algebraic Mind, The Birth of the Mind, Kluge: The Haphazard Evolution of the Human Mind, The New York Times Bestseller, Guitar Zero and The Future of the Brain: Essays By The World’s Leading Neuroscientists.

 

In a 2012 essay for The New Yorker, he was perhaps the first person to publicly criticize deep learning, drawing on arguments he developed in his 2001 technical book The Algebraic Mind. More recently, in a 2018 arXiv article, Deep Learning: A Critical Appraisal, he asked whether deep learning might be “approaching a wall.” The challenges he laid out there were covered everywhere from The
New York Times to Wired to The Financial Times and Wall Street Journal.

 

In another provocative 2012 essay, Moral Machines, Marcus was the first to adapt “trolley problems” to driverless cars, anticipating much recent research on the ethics of AI. His next book, REBOOT: Getting to AI We Can Trust, to be published by Pantheon in Fall 2019, co-authored with Ernie Davis, calls for a fundamental rethinking of current approaches to artificial intelligence.

BERTRAND BODSON
Chief Digital Officer
Novartis Foundation
BERTRAND BODSON
Chief Digital Officer
Novartis Foundation

Bertrand Bodson has been Chief Digital Officer of Novartis since January 1, 2018. He is a member of the Executive Committee of Novartis.

 

From 2013 to 2017, Mr. Bodson served as Chief Digital and Marketing Officer of Sainsbury’s Argos, where he led Argos’ successful transformation from a traditional catalogue business to the third-largest online retailer in the United Kingdom.

 

Prior to that, he was Executive Vice President of the global digital business at EMI Music from 2010 to 2013. He co-founded Bragster.com, a social networking and content sharing website, and has also held senior roles at Amazon.

 

Mr. Bodson earned a Master of Business Administration from Harvard Business School in the United States, where he was a Baker Scholar, and a master’s degree in commercial engineering from the Solvay Business School (Belgium)/McGill University (Canada). He is a member of the Board of Directors of Electrocomponents PLC.

PROF. DR. EFFY VAYENA
Professor
Institute of Translational Medicine
PROF. DR. EFFY VAYENA
Professor
Institute of Translational Medicine
DR. RAMYA PALACHOLLA
Lead Scientist & Faculty
Partners Healthcare & Harvard Medical School
DR. RAMYA PALACHOLLA
Lead Scientist & Faculty
Partners Healthcare & Harvard Medical School

Ramya Palacholla is a Physician and one of the Lead Scientists at Partners Healthcare Pivot Labs. She is also a faculty member of the Harvard Medical School. Currently, Dr. Palacholla works with a multidisciplinary team that develops and executes digital health strategy and research projects in collaboration with top pharmaceutical, research and medical technology companies. She is passionate about her research focused on validation of innovative health technology solutions for improving patient lives. Dr. Palacholla has published her work in several health care journals and presented her research on innovative technologies on international platforms such as the World Economic Forum (also presented at the G8 Summit), served as a reviewer for health technology journals, and spoken at national conferences as a thought leader in the field of health care research and innovation. Her cutting edge research in this area is recognized for its high caliber, and she continues to advance this field to new frontiers. Dr. Palacholla’s idea on an “Innovative Tumor Response Forecasting Model in Breast Cancer Patients” was awarded the first position in the Harvard Ideation Challenge among hundreds of submissions received from across the country. Furthermore, the idea was also selected as one of the top six finalists for the Boston Scientific and Google Connected Patient Challenge, 2018, which is unquestionably a renowned platform that showcases healthcare innovations across the globe. She was also a co-author of one of the first books to be written on proven treatment methods for the management of Military Sexual Trauma and PTSD in war veterans. Following these successes, Dr. Palacholla’s research is well-known in the healthcare innovation space and has given her opportunities to present her research work at national healthcare conferences and summits.

PROF. WEIHONG HUANG
Mobile Health Ministry of Education - China Mobile Lab
Xiangya Hospital Central South University
PROF. WEIHONG HUANG
Mobile Health Ministry of Education - China Mobile Lab
Xiangya Hospital Central South University

Weihong Huang received the B.Eng. degree in automation and M.Eng. degree in pattern recognition and smart control from Southeast University China in 1995 and 1998 respectively and the Ph.D. degree in computer science from Nanjing University China in 2001. From 2001 to 2002, he was a Post-doctoral Research Fellow with the CNRS University Lyon 1 France. From 2002 to 2005, he was a lecturer with the Department of Computer Science, University of Hull, United Kingdom. From 2005 to 2014, he was a senior lecturer with School of Computer and Information Systems, Kingston University London, United Kingdom. Since 2016, he was appointed as a professor and the Depute Director of the Mobile Health Ministry of Education – China Mobile Joint Laboratory, Xiangya Hospital Central South University, China. His research interests include mobile health, artificial intelligence in healthcare, cognitive computing for healthcare, semantic multimedia computing and knowledge graph applications. Prof. Huang is a committee member of China Hospital Information Management Association, standing committee member of the Medical and Health Big Data Evaluation and Assurance board of the Chinese Health Information and Big Data Association, chairman of specialized committee of information management of Hunan Health Management Association.

ANNE O'RIORDAN
Senior Managing Director
Accenture Life Sciences
ANNE O'RIORDAN
Senior Managing Director
Accenture Life Sciences

Anne is the global Industry Senior Managing Director for Accenture’s Life Sciences business and a global client lead.  She has been with Accenture for 28 years.  Over this period she has worked across the US, Europe and Asia with global companies transforming their business and operating models, to meet changing market and portfolio needs.  She has been in China since 2007 and has been on the board of the global Products Operating Group of Accenture since 2006.  She has published numerous articles over the past 20+ years. Her most recent publication is a book entitled ‘Healthcare Disrupted: Next Generation Business Models and Strategies@ (Wiley Feb 2016)”.   Based in Hong Kong, Ms. O’Riordan is a member of The Women’s Foundation, the 30% Club and co-chair of the Women of Influence Committee at the American Chamber of Commerce.

DR. ASIF JAN
Group Director of Analytics in Personalised Healthcare
Roche 
DR. ASIF JAN
Group Director of Analytics in Personalised Healthcare
Roche 

Asif Jan leads a multidisciplinary team of scientists specializing in computer science, neuroscience, and statistics. The team implements a variety of statistical and machine learning methods on real-world datasets (e.g. electronic medical records, health insurance claims, disease registries) to fulfill evidence and data analysis needs of the Neuroscience disease area at Roche. Previously, he was Head of Data Science at Roche Diagnostics leading a team of quantitative scientists supporting in vitro diagnostics and clinical decision support product development, where he defined data strategy enabling the use of real-world data. Earlier he has had a number of roles overseeing technology strategy development, enterprise and solution architecture, and program management at Roche and in other research organizations. Asif has vast experience of building and leading data science teams in pharma and diagnostics companies, and industrial research institutes, tackling complex scientific and business problems. He strongly believes that the intersection of strategy, technology and data science is needed to fight diseases, thereby enabling better care for everyone.

Asif holds a PhD in Neuroscience (informatics) from the Swiss Federal Institutes of Technology Lausanne (EPFL), Switzerland, and an MPhil in Computer Science from the University of the West of England, Bristol, UK.

ALLESANDRO CURIONI
IBM Fellow, Vice President Europe and Director
IBM Research
ALLESANDRO CURIONI
IBM Fellow, Vice President Europe and Director
IBM Research

Dr. Alessandro Curioni is an IBM Fellow, Vice President of IBM Europe and director of the IBM Research Lab in Zurich, Switzerland. He was also recently appointed as the Watson IoT Research Relationship Executive.

Dr. Curioni is an internationally recognized leader in the area of high-performance computing and computational science, where his innovative thinking and seminal contributions have helped solve some of the most complex scientific and technological problems in healthcare, aerospace, consumer goods and electronics. He was a member of the winning team recognized with the prestigious Gordon Bell Prize in 2013 and 2015.

Dr. Curioni received his undergraduate degree in Theoretical Chemistry and his PhD from Scuola Normale Superiore, Pisa, Italy. He started at IBM Research – Zurich as a PhD student in 1993 before officially joining as a research staff member in 1998. His most recent position was Head of the Cognitive Computing and Computational Sciences department.

DR. NATALIE BANNER
Understanding Patient Data Lead
Wellcome Trust
DR. NATALIE BANNER
Understanding Patient Data Lead
Wellcome Trust

Dr Natalie Banner is the Lead for Understanding Patient Data (UPD), an initiative hosted at the Wellcome Trust to support better conversations about how patient data is used for care and research. UPD works with patients, charities and health professionals to champion responsible uses of data, feeding into policy development, creating accessible resources and horizon scanning for emerging issues that may affect public confidence in the use of health data.

 

This includes exploring emerging data-driven technologies and how to create the right ethical and governance frameworks for these in healthcare and research. Natalie formerly led Wellcome’s policy work on GDPR and data protection, seeking to ensure UK legislation and regulation creates a supportive, trustworthy environment for health research using patient and health-related data. She was recently named in BioBeat’s “50 Movers and Shakers in BioBusiness” for 2018.

ROLAND ROTT
Global General Manager of Women's Health Ultrasound
GE Healthcare
ROLAND ROTT
Global General Manager of Women's Health Ultrasound
GE Healthcare

Roland Rott is the global General Manager of Women´s Health Ultrasound at GE Healthcare, the market leader of Ultrasound for Obstetrics/Gynecology worldwide. The Voluson product line for Women´s Health has been pioneering Ultrasound and AI technology and is touching more than 250 million lives globally every year.


Roland leads the global product organization, consisting of clinical and product management, research & development, installed base customer service, quality management and is responsible for innovation and manufacturing sites in Austria, Germany and Korea.

 

Before joining GE in 2011, Roland was Managing Director EMEA and Executive board member of Exact Software – a midcap public company headquartered in the Netherlands – leading 4 R&D teams and subsidiaries in 20 countries spanning over Europe/Middle/East, Africa & Asia. In his early career, Roland had an entrepreneurial start, founded two software companies in Austria and successfully sold those to strategic investors.


Roland has a software engineering background, studied International business administration and took executive education courses on strategy and Innovation in Stanford University and the London Business school. He is based in Vienna, Austria and lives there with his wife, two teenage kids and a toddler
.

DR. STEPHANIE KUKU
Senior Consultant
Hardian Health
                               
DR. STEPHANIE KUKU
Senior Consultant
Hardian Health
                               

Stephanie is a health technology advisor in digital health and artificial intelligence.  She has over 15 years clinical and research experience and trained and worked in the NHS as a surgical oncologist specialising in women’s cancers.

 

Stephanie is an advisor and consultant in Clinical AI at the World Health Organisation’s Department of Digital Health & Innovation.  She is the Healthcare Lead for Women in AI (WAI), an NHS England Clinical Entrepreneur and Honorary Senior Research Fellow at UCL where she was awarded a Doctorate in Clinical Research.

 

During her clinical career she sat on council of a national cancer society (BGCS) and was awarded numerous International travelling fellowships to; Memorial Sloane Kettering Cancer Center in New York, Cancer Hospital Pernambuco in Brazil, and Centre du Cancer Oscar Lambret in France.

 

Stephanie is a regular speaker on validation of health technology and has hosted a US podcast (HLTH) on themes around technology and the future of health.

ELENA BONFIGLIOLI
Managing Director Health and Life Sciences
Microsoft EMEA
ELENA BONFIGLIOLI
Managing Director Health and Life Sciences
Microsoft EMEA

Elena Bonfiglioli, Managing Director Health and Life Sciences, Microsoft EMEA
Elena Bonfiglioli leads the Health and Life Sciences Industry business for Microsoft in Europe, Middle East and Africa, and is part of the World Wide Commercial Business Team. She is responsible for driving strategy and business development, partnerships, and positioning for the region across public health, social services, providers, and pharma. Elena is an advocate for the transformation of healthcare systems with Cloud and AI.

SALVATORE SCALZO
Policy and Legal Officer
European Commission
SALVATORE SCALZO
Policy and Legal Officer
European Commission

Salvatore Scalzo has been working for more than seven years in the European Commission. Since November 2013, he is Policy and Legal Officer in the Unit dealing with legislation on medical devices (currently unit D4 of the Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs). After having dealt with the negotiations of the proposed new Regulations on medical devices which were adopted in spring 2017, he is currently working on the legal interpretation and implementation of those Regulations and coordinating, among other tasks, the activities of the European Commission Expert Groups on medical device identification and traceability and medical software. 

AMIR SAFFARI
SVP of AI
BenevolentAI
AMIR SAFFARI
SVP of AI
BenevolentAI

Amir Saffari has a PhD in Machine Learning and has been working in the field of Artificial Intelligence for more than 17 years, researching and developing ML theory, applications, and products. He’s numerous publications in top-tier ML conferences and journals and most of his research has been released as open source software. He was part of Sony’s R&D team and has been involved in a few ML startups prior to joining BenevolentAI where he is currently leading the research and development of ML technology to drug discovery.

DANIEL NATHRATH
Co-Founder and CEO
Ada Health
DANIEL NATHRATH
Co-Founder and CEO
Ada Health

Daniel is a serial entrepreneur with 20 years’ experience in strategic growth and transformational change. During his career, he’s founded several startups around the world and served as general counsel and managing director at various tech firms across the UK, US, Denmark and Germany. Daniel was a consultant at the Boston Consulting Group and studied law as a Fulbright Scholar at the University of Houston. He holds an MBA from the University of Chicago. 

CHRIS GIBSON
Co-Founder and CEO
Recursion Pharma
CHRIS GIBSON
Co-Founder and CEO
Recursion Pharma

Chris Gibson, PhD, is the Co-Founder and CEO of Recursion Pharmaceuticals, a biotech company leveraging the latest in automation, artificial intelligence and biology to do drug discovery at scale. Chris developed the technology and approach underlying Recursion as part of his MD/PhD graduate work in the lab of Co-Founder Dr. Dean Li at the University of Utah. Chris left medical school to transform this technology into the rapidly growing company it is today. Chris is a graduate of Rice University with degrees in bioengineering and managerial studies, as well as a graduate of an intense entrepreneurship course at Stanford GSB. He is a Board Member of CureHHT, a patient advocacy group for Hereditary Hemorrhagic Telangiectasia, and a member of the Rare and Undiagnosed Network Advisory Board. Outside of work, Chris enjoys cycling on both the road and the trails that cut through Utah’s great wilderness, as well as spending time with family.

Dr. FARZANA RAHMAN
Consultant Radiologist UCLH | NHS Digital
Clinical Advisor, Data and Digital Strategy Lead | The Academy of Medical Royal Colleges
Dr. FARZANA RAHMAN
Consultant Radiologist UCLH | NHS Digital
Clinical Advisor, Data and Digital Strategy Lead | The Academy of Medical Royal Colleges
DR. SATCHIT BALSARI
Assistant Professor in Emergency Medicine
Harvard Medical School (Beth Israel Deaconess Medical Center)
 
DR. SATCHIT BALSARI
Assistant Professor in Emergency Medicine
Harvard Medical School (Beth Israel Deaconess Medical Center)
 
JOSE PEDRO ALMEIDA
Director of Big Data Analytics and Machine Learning
São João Hospital Center
JOSE PEDRO ALMEIDA
Director of Big Data Analytics and Machine Learning
São João Hospital Center

He was named top-20 Portuguese world changer and he is a leading expert in the real-world application of Advanced Analytics & Machine Learning to Hospital problems, transforming sparse patient’s BigData into actionable clinical insights. His team built one of the most outstanding Hospital Big Data platforms currently working in EU hospitals. This platform behaves like a “Data Robot” that captures and analyses 560 billion patient data points\minute, coming from 30 different systems, to predict and signal at-risk patients for clinical deterioration up to 7 days in advance. This work has received some of the highest in the industry, amongst which the 1st prize in the HIMSS Europe Digital Healthcare 2016 Award (Barcelona), the 1st prize in the “2014 Microsoft Worldwide Health Innovation Award (MSHUG)” (Orlando, USA) and the 2014 “Big Data & Analytics Solution of the Year” prize by IT Europa (London, UK).

HUGUETTE DIAKABANA
Co-Founder
African Alliance of Digital Health Networks
HUGUETTE DIAKABANA
Co-Founder
African Alliance of Digital Health Networks
DR. DIVYA CHANDER
Faculty Chair in Neuroscience & Faculty in Medicine
Singularity University
     
DR. DIVYA CHANDER
Faculty Chair in Neuroscience & Faculty in Medicine
Singularity University
     

Dr. Chander is a physician, neuroscientist, and futurist who trained at Harvard, UCSD, UCSF, and the Salk Institute. She is Chair of Neuroscience and Faculty of Medicine at Singularity University, Visiting Scholar in Medicine at Stanford (where she was on faculty for 8 years), and Senior Non-Resident Fellow at the Atlantic Council GeoTech Center. She has also co-founded and leads 2 companies during the pandemic – Lucidify, a tele-neuroICU platform, and Plexxus, a company building the world’s connected global immune system. Dr. Chander also serves on a NASA-White House task force for COVID19, and both co-chairs and directs the post-pandemic global health initiative for OneShared.World. Her research interests center around mapping human consciousness, how consciousness will be altered by human augmentation, and how mapping consciousness in humans may enable us to recognize it in non-human, intelligent beings (both on and off-planet). In 2004, she was a finalist for astronaut selection, and has since maintained a passion for building medical systems in space to sustain human exploration.

JUNAID BAJWA
Chief Medical Scientist
Microsoft Research
         
 
JUNAID BAJWA
Chief Medical Scientist
Microsoft Research
         
 

Junaid is the Chief Medical Scientist at Microsoft Research and a practising physician in the NHS (the UK’s National Health Service). He was previously the Global Lead for Strategic Alliances and Solutions for the Global Digital Centre of Excellence at Merck Sharp & Dohme, where he led a range of strategic initiatives to improve patient care, including establishment of internal partnerships across the enterprise and external partnerships across the health care ecosystem. He cofounded “VelocityHealth” as Europe’s first prevention focused digital-health accelerator, in partnership with Telefonica, and led his team to deliver the “NHS Testbed” in partnership with Verily Life Sciences (part of Alphabet), which the Health Service Journal recognized as the “Best Pharmaceutical Partnership with the NHS” in 2018.

Previously, Junaid has worked across primary care, secondary care, and public health settings in addition to acting as a payer, and policy maker within the UK, where he specialized in informatics, digital transformation, and leadership. He has consulted for health care systems across the US, Australia, New Zealand, Singapore, and Europe, in addition to being seconded by the NHS to work with IBM. Junaid completed his MBA at the Imperial College Business School in London and has studied health strategy and quality improvement at both Harvard and the Institute of Healthcare Improvement in Boston. Academically, he is a Clinical Associate Professor at UCL (University College London), and Visiting Scientist at the Harvard School of Public Health.

Junaid hopes to bring his clinical, life sciences, and academic experiences together in this new role. He hopes to help healthcare focused teams across Microsoft, unlock the power of technology to help solve the healthcare challenges of today, whilst reimagining a better future for tomorrow.

 

ANTONIO RUSSO
AI, Innovation and Future of Health Lead
Deloitte
       
ANTONIO RUSSO
AI, Innovation and Future of Health Lead
Deloitte
       

Antonio leads Deloitte’s Analytics & Cognitive Advisory in Switzerland and is responsible for Innovation within Deloitte Switzerland’s Executive team. His team helps clients leverage the power of artificial intelligence and data to deliver more customer-centric and innovative products and services that catalyse growth and efficiencies.

He has over 20 years of experience in advising companies in large-scale global transformations, leveraging new delivery models (GBS/SSC, outsourcing) and innovative technologies (e.g. robotics, machine learning, natural language processing/generation). He helps global private sector and financial services organisations review and implement new strategies for business support functions, and deploy more effective and efficient services and governance models. Prior to joining Deloitte in April 2013, he held various sales and consulting leadership positions across Europe and was CEO of a start-up company developing brand protection technologies.

RAMATOULIE JALLOW
Connector and Administrator
Pan African Women in Health
         
 
RAMATOULIE JALLOW
Connector and Administrator
Pan African Women in Health
         
 

Ramatoulie is a Public Health Consultant and Health Communications Specialist. She holds an MPH in Community Health Promotion, with an interdisciplinary concentration in Global Health, from the University of Minnesota, USA. Ramatoulie is a Connector and Administrator for the Pan African Women in Health (PAWH) virtual platform which creates a space for African women health professionals to connect and provide or receive mentorship.

Presently, she works as a Stigma Index Researcher with the Global Network for People living with HIV (GNP+). Previously, she served as an Epidemiologist, with the US Centers for Disease Control and Prevention, conducting surveillance of the West Africa Ebola outbreak in Guinea and providing technical assistance to the Ministry of Health and to the Expanded Program of Immunization’s supplemental immunization activities for polio eradication. Prior to joining CDC, she conducted HIV/AIDS research in Kigali, Rwanda, as a Global Health Corps fellow, and worked as an HIV/AIDS Medical Case Manager in Minnesota, USA. As a Consultant, she has worked on a variety of projects related to women’s empowerment and the demographic dividend in the Sahel as well as on youth access projects and family planning services in Senegal. Ramatoulie is an avid mentor and an advocate for girls and women’s sexual and reproductive health rights. She is also a member of Scientists of the Gambia, Paradise Foundation’s COVID-19 Coordination team, and EyeToo; initiatives founded by young Gambians, both in the diaspora and at home, to encourage more youth to pursue STEM careers, improve health messaging around COVID-19, and to address accessibility and affordability of vision care in The Gambia, respectively. She is presently based in Yaoundé, Cameroon.

BONIFACIA AGYEI
Country Director of SafeCare, PharmAccess Ghana
PharmAccess Group
         
 
BONIFACIA AGYEI
Country Director of SafeCare, PharmAccess Ghana
PharmAccess Group
         
 

As highly skilled assessor and quality improvement facilitator, Bonifacia Benefo Agyei works passionately with healthcare facilities to support improvement in healthcare quality and patient safety using her rich experience in healthcare system management from both public and private sectors. Bonifacia advocates for healthcare quality improvement in Ghana using international quality standards and digital innovations. 

Bonifacia has been working at PharmAccess since 2012 where she currently leads and manages the entire SafeCare Program and other quality related programs provided by PharmAccess Ghana. Among others, this includes directing and coordinating all quality and technical services, while collaborating with public and private partners to support the institutionalization of quality improvement and the digitalization of healthcare in Ghana. She has a range of healthcare management experience, in quality improvement, business development as well as in the development and roll-out of digital innovations.

Prior to joining PharmAccess, she served as Accreditation Quality Officer and Clinical at the National Health Insurance Authority (NHIA), Ghana after almost ten years of experience serving in various nurse management roles and responsibilities in public and private health facilities. She also has extensive experience in training, mentoring, development of quality standards, manuals and curriculum; such as for the novel maternal healthcare franchise network (Woman360) in Ghana. Among other qualifications, Bonifacia holds a bachelor’s degree in nursing, a master’s degree in public administration and is a Fellow in the International Society for Quality in Health Care program (ISQua).

PROF LUCIANO FLORIDI
Professor of Philosophy and Ethics of Information and Director
The University of Oxford and Digital Ethics Lab
PROF LUCIANO FLORIDI
Professor of Philosophy and Ethics of Information and Director
The University of Oxford and Digital Ethics Lab

Luciano Floridi is the OII’s Professor of Philosophy and Ethics of Information at the University of Oxford, where he is also the Director of the Digital Ethics Lab of the Oxford Internet Institute. Still in Oxford, he is a Distinguished Research Fellow of the Uehiro Centre for Practical Ethics of the Faculty of Philosophy, and Research Associate and Fellow in Information Policy of the Department of Computer Science. Outside Oxford, he is Faculty Fellow of the Alan Turing Institute (the national institute for data science) and Chair of its Data Ethics Group; and Adjunct Professor (“Distinguished Scholar in Residence”) of the Department of Economics, American University, Washington D.C.

 

His research concerns primarily Information and Computer Ethics (aka Digital Ethics), the Philosophy of Information, and the Philosophy of Technology. Other research interests include Epistemology, Philosophy of Logic, and the History and Philosophy of Scepticism. He has published over 150 papers in these areas, in many anthologies and peer-reviewed journals.

Prof. MARCE SALATHE
Associate Professor
EPFL
 
Prof. MARCE SALATHE
Associate Professor
EPFL
 

Marcel Salathé is a digital epidemiologist working at the interface of population biology, computational sciences, and the social sciences. He obtained his PhD at ETH Zurich and spent two years as a postdoc in Stanford before joining the faculty at Penn State in 2010 at the Center for Infectious Disease Dynamics. In 2014, he spent half a year at Stanford as visiting assistant professor. In the summer of 2015, Marcel became an Associate Professor at EPFL where he heads the Digital Epidemiology Lab at the new Campus Biotech. In 2016, he has also been appointed Academic Director of EPFL Extension School, whose mission is to provide high quality online education in digital technology.

HILA AZADZOY
Managing Director, Global Health Initiative
Ada Health
         
 
HILA AZADZOY
Managing Director, Global Health Initiative
Ada Health
         
 

Hila leads our Global Health Initiative to improve access to healthcare in resource-limited countries. Before Ada, Hila was a founding member and Head of Academics at Kiron Open Higher Education. She is a Digital Female Leader Award recipient, an MIT Solve Member, and a talented public speaker (TEDx, Clinton Global Initiative, UNESCO NGO Forum). “I am dedicated to using technology for social good.”

DR. ALISON DARCY
Founder and President
Woebot Health
         
 
DR. ALISON DARCY
Founder and President
Woebot Health
         
 

Alison is a clinical research psychologist and health tech visionary dedicated to creating smart, scalable and accessible mental healthcare solutions. Her work to explore how digital treatments can help solve human problems began more than 20 years ago, when she created one of the first online support groups for people with eating disorders.

That work led to PhD level studies in psychology at University College Dublin and post-doctoral training at Stanford School of Medicine and with the American Psychiatric Association. At Stanford, Alison also worked with AI pioneer Andrew Ng to explore the intersection of AI and healthcare, leading his Health Innovation Lab in Computer Science.

A frequent speaker on digital therapeutics design and development, barriers to care, and engagement, Alison has authored more than 40 publications and been awarded research grants and contracts from the NIH, the Davis Foundation and APA. She is also currently an Adjunct Lecturer in the Psychiatry and Behavioral Sciences Department of Stanford’s School of Medicine. Alison holds a PhD, an MLitt and a Bachelor of Arts degree in psychology from University College Dublin.

JOÃO ARTHUR REIS
Director - Science, Technology and Innovation Coordination
São Paulo State Government
         
 
JOÃO ARTHUR REIS
Director - Science, Technology and Innovation Coordination
São Paulo State Government
         
 

João works in the design and implementation of ST&I policy in the State of São Paulo and has previously worked with innovative entrepreneurship and international cooperation at the Maranhão Foundation for Research, Science and Technology Development – FAPEMA, through Vetor Brasil’s Public Sector Trainee Program, which develop young professionals in their careers in local and state governments in Brazil. João holds a Bachelor’s degree in International Relations – Federal University of Rio Grande do Sul and a M.A. in International Political Economy – Federal University of Rio de Janeiro.

LAURA MCGORMAN
Policy Lead, Data for Good
Facebook
         
 
LAURA MCGORMAN
Policy Lead, Data for Good
Facebook
         
 
Dr. ANDRE CHOW
Co-Founder
Digital Surgery
Dr. ANDRE CHOW
Co-Founder
Digital Surgery

Andre gained a BSc degree in Surgical Technology and graduated from Imperial College School of Medicine in 2004. He began his surgical training at St. Mary’s Hospital in London and in 2006 became a full member of the Royal College of Surgeons.  In 2008 he was awarded one of three places as an Academic Clinical Fellow, and in 2009 was appointed a Clinical Innovation Fellow at Imperial College London. In 2010 he was awarded a prestigious Welcome Trust Research Fellowship to pursue research in the fields of stem cell technology & biomaterials, and completed his PhD at Imperial College in 2012.  Andre has over 30 peer-reviewed journal publications to his name and has also authored several book chapters. He has been an invited speaker at international surgical conferences on the subject of surgical quality assessment, and regularly presents on medical entrepreneurship and surgical training.

DR. JAY MANDREKAR
Professor of Biostatistics & Neurology
Mayo Clinic
   
DR. JAY MANDREKAR
Professor of Biostatistics & Neurology
Mayo Clinic
   

Jay Mandrekar, Ph.D., is the primary statistician for the Mayo Clinic Department of Neurology, and the Divisions of Infectious Diseases and Clinical Microbiology. He is involved in multiple clinical trials, population-based studies and research grants in these areas.

Dr. Mandrekar’s primary research interest is in the application and extension of statistical methods for the evaluation of the quality and domains of clinical teaching, multiple sclerosis and other neurologic diseases, prosthetic joint infections, and assays for viral detection.

 

RACHEL SIBANDE
Program Director - Data for Development
Digital Impact Alliance, at the United Nations Foundation
         
 
RACHEL SIBANDE
Program Director - Data for Development
Digital Impact Alliance, at the United Nations Foundation
         
 

Rachel Sibande is Program Director, Data for Development at the Digital Impact Alliance, a unit within the United Nations Foundation. She leads sector wide Big data for development models across countries in Africa, supporting Governments to leverage the power of Big data for decision making. Recently, Rachel has led the development of risk and epidemiology models for COVID19 that integrate mobility metrics generated from Mobile Network Operator data and Geospatial data. The models would help Governments understand where to anticipate COVID19 hotspots, stock outs and health facility burden prior. These Big Data models have been developed for Malawi and 14 other West African Countries under the West African Health Organisation regional block. Rachel is  also leading on the integration of geospatial data, mobile network operator data and immunisation data to enhance immunisation outcomes in Tanzania.She has also led the development of resources used by practitioners in the big  data for development space to get started deploying similar initiatives. Her work cuts across a new space in the Big Data and AI space as it seeks to  integrate traditional digital health data and non traditional data sets such as mobile network operator data  largely to help understand mobility patterns of people and how they impact health outcomes.

Dr. DANIEL VERES
Chief Medical Officer
Turbine
Dr. DANIEL VERES
Chief Medical Officer
Turbine

Dániel is the creator of the first compartmentalized protein-protein interaction database, with years of experience building computational models in order to understand the behaviour of human cells. As a medical doctor, Daniel translates computational results into clinical interpretations, indispensable to design innovative and relevant treatments to defeat cancer.

CHARLES ROBERTS
Co-Founder and Chief Partnerships Officer
Freenome
CHARLES ROBERTS
Co-Founder and Chief Partnerships Officer
Freenome

A clinician by training, Charlie is Freenome’s Chief Partnership Officer, focusing on mid- and longer-term relationships that will help define the company’s future directions and revenues and works closely with the business development team in managing corporate client accounts and institutional collaborations. Prior to co-founding Freenome, Charlie co-founded a company that uses circulating cell-free (cf)DNA from maternal blood samples to diagnose chromosomal abnormalities during pregnancy. The resulting in-vitro diagnostic, IONA, has been marketed successfully across Europe and the Middle East. Charlie studied medicine and neuropsychology in the UK, earning a Masters degree from Oxford with a focus on immunotherapy. He has worked in some of the UK’s leading oncology centers, including the Royal Marsden.

DR. LOUBNA BOUARFA
CEO and Founder & High Level Expert on AI
OKRA Technologies & European Commission
DR. LOUBNA BOUARFA
CEO and Founder & High Level Expert on AI
OKRA Technologies & European Commission

Dr Loubna Bouarfa is a machine learning scientist turned entrepreneur.

 

She is the founder and CEO of OKRA Technologies – an artificial intelligence data analytics company for healthcare. OKRA allows healthcare professionals to combine all their data in one place and generate evidence-based insights in real time, to save and improve human lives. Loubna is currently a member of the European Union High-Level Expert Group on Artificial Intelligence, where she is particularly focused on healthcare and achieving competitive business impact with AI. She was named an MIT Technology Review Top Innovator Under 35, a Forbes 50 Top Women In Tech, and recently won the prize for Best Female-Led Startup at the StartUp Europe Awards. On a personal level, she is a strong advocate for diversity, women and challenging the status quo.

 

For more information on OKRA, visit ​okra.ai​ and find us on ​LinkedIn​ and ​Twitter​. 

EYAL TOLEDANO
Co-Founder and CTO
Zebra Medical VisionVision
EYAL TOLEDANO
Co-Founder and CTO
Zebra Medical VisionVision

Eyal Toledano is co-founder and CTO of Zebra Medical Vision; Eyal focuses on innovation in medical imaging machine vision. Graduated with Master of Science from the MIT Media Lab. Eyal served for more than 8 years as the CTO and Advanced Technology GM for Samsung Israel R&D (STRI/Yakum). Before co-founding the Israeli R&D of Samsung Eyal was leading the development of challenging projects at Sun Microsystems. Eyal completed 7 years of military service in the IDF Elite Intelligence Technologies. Eyal still hacks code every day and enjoys making morning sandwiches.

MAGNUS CONTEH
Executive Director, Community Health Academy
Last Mile Health
MAGNUS CONTEH
Executive Director, Community Health Academy
Last Mile Health

Magnus Conteh joined the Last Mile Health team in 2018 to help lead the Community Health Academy, which aims to reinvent the education of community health workers – and the health system leaders who support them – for the digital age.

Magnus brings over 25 years of senior level experience in education, global health, and digital health to Last Mile Health. Previously, Magnus worked for seven years at World Vision Ireland, most recently serving as the Deputy CEO/Director of Programmes and Strategy. Notably, he led World Vision’s involvement in the Johnson & Johnson/Janssen Ebola Vaccine trial in Sierra Leone, which included overseeing the deployment of technology critical for the clinical trial. In addition to serving as a member of the World Vision International Digital Health Steering Committee, he forged multi-stakeholder collaboratives and digital health partnerships with a number of governments, mobile network operators, and other INGOs in Africa.Prior to joining World Vision Ireland, he held a number of senior management positions in the National Health Service in the UK and the Health Service Executive in Ireland, where he served as Director for the Regional Centre of Nursing/Midwifery Education at the University Hospital in Galway. Magnus holds a Masters of Health Science (Hons) in Health Services Research from the National University of Ireland, Masters of Arts in Health Service Policy and Management from Brunel University (UK), and a Postgraduate Diploma in Management Studies from Kingston Business School at Kingston University (UK).

DR. JON SORENSON
Head of Cheminformatics
Atomwise
DR. JON SORENSON
Head of Cheminformatics
Atomwise

Jon Sorenson, Ph.D., is head of the cheminformatics team at Atomwise. Jon has nearly 20 years of experience in computational biology and software leadership, ranging from senior contributor roles to executive management of 100+ person teams spanning computational biology and software operations. He has held senior leadership roles at Applied Biosystems, Pacific Biosciences, Invitae and 10X Genomics, and he is co-author on more than 30 publications and patents. At Atomwise, Jon is thrilled to have returned to his first passion of computational drug design, a field that he first encountered as a college intern working at Merck Research. Before joining industry in 2000, he obtained a Bachelor of Science in chemistry and mathematics from Harvey Mudd College, a Master of Philosophy in theoretical chemistry from the University of Cambridge and a Doctor of Philosophy in computational chemistry from the University of California, Berkeley.

DR. BORIS BOGDAN
Managing Director, Lead - Global Precision Oncology and Personalized Healthcare (PHC)
Accenture Life Sciences
DR. BORIS BOGDAN
Managing Director, Lead - Global Precision Oncology and Personalized Healthcare (PHC)
Accenture Life Sciences
DR. MANUEL GARCÍA-HERRANZ
Chief Scientist
UNICEF
         
 
DR. MANUEL GARCÍA-HERRANZ
Chief Scientist
UNICEF
         
 

Dr. Manuel García-Herranz is Chief Scientist at UNICEF’s Office of Innovation and Information and Communications Technology Division joint initiative on Big Data and Artificial Intelligence. He has been working with UNICEF for more than 6 years to bridge the gap between Data Science and the needs of the most vulnerable children. At UNICEF, he co-created the MagicBox program to build research and partnerships that can transform Big Data and Artificial Intelligence into equitable tools to better respond to epidemics or natural disasters and deliver results to the most vulnerable populations. Through the Science team, UNICEF Innovation has also been focusing on the future of digital vulnerabilities, working to identify and curve emerging computational inequalities such as bias in new sources of data and unfairness in algorithms. Manuel holds a PhD in computer science from the Universidad Autonoma de Madrid.

DR. OLIVER MORGAN
Director of Health Emergency and Risk Assessment
World Health Organization
DR. OLIVER MORGAN
Director of Health Emergency and Risk Assessment
World Health Organization

Dr. Oliver Morgan is the Director of the Health Emergency Information and Risk Assessment Department in the WHO Health Emergencies Program. From 2007 through 2016, Dr. Morgan worked for the US Centers for Disease Control and Prevention during which time he held critical leadership positions in the Ebola response between November 2014 and February 2016 (CDC Atlanta Ebola Response Incident Manger and CDC Country Director in Sierra Leone).From March 2010 to October 2014, Dr. Morgan was the CDC Country Director in the Dominican Republic. Dr. Morgan was an Epidemic Intelligence Service Officer at CDC from 2007 to 2009 with the International Emerging Infections Program, during which time he conducted projects in Thailand, Bangladesh, Kenya, Uganda, and Guatemala. Before joining CDC, Dr. Morgan worked for the UK Health Protection Agency, leading epidemiological investigations of outbreaks (enteric, vaccine preventable, hospital acquired, zoonotic, respiratory, and sexually acquired infections), chemical and radiation exposure incidents, terrorist bombings in London, natural disasters, and humanitarian civil conflicts. Dr. Morgan has also worked as a consultant to WHO/PAHO in several countries. Dr. Morgan’s academic achievements include a doctorate in epidemiology from Imperial College London and extensive publication in peer reviewed journals and reference books.

JENNY BARNETT
Chief Scientific Officer
Cambridge Cognition
JENNY BARNETT
Chief Scientific Officer
Cambridge Cognition

Named one of the 40 most influential Healthcare Technology Transformers in 2017, Jenny is responsible for ensuring that all our neuroscience products and services meet the highest scientific standards, as well as the practical needs of researchers, doctors and patients.  Jenny joined Cambridge Cognition in 2008 and has worked in a variety of roles across the clinical trials and healthcare arms of the business. She led research and development activities for groundbreaking products such as CANTAB Mobile, an iPad-based medical device used to test for the first signs of Alzheimer’s disease, and Cognition Kit, a mobile and wearables platform for the remote monitoring of brain health.

Jenny has an MA in Experimental Psychology from Oxford University, a PhD in psychiatric epidemiology from the University of Cambridge, and completed post-doctoral work at Massachusetts General Hospital and the Broad Institute of Harvard and MIT. She is an Honorary Research Fellow at the University of Cambridge Department of Psychiatry, a team member of the Oulu University, Northern Finland Birth Cohorts, and the author of more than 50 academic publications covering topics ranging from psychology and neuroscience to genetics and health economics.

CLARA PALAU
Technology Team Lead
UNICEF
CLARA PALAU
Technology Team Lead
UNICEF

Clara Palau is the product manager for UNICEF’s Magic Box, an initiative focused on using data science and artificial intelligence to support humanitarian and development programmes for the most vulnerable children, by enabling partnerships through private sector, academia and public organisations.  

Before joining UNICEF, she gained international experience as a manager and as a researcher in different industries and technology areas, working for Orange, CERN and Indra. She holds a MsC in telecommunication engineering and a master in non-profit organisation management.

STEVE GUISE
Global Head of Informatics
Roche Pharmaceuticals 
STEVE GUISE
Global Head of Informatics
Roche Pharmaceuticals 

Steve Guise has been Global Head of Informatics for Roche Pharmaceuticals since October 2016. During these nearly two years, Steve has built and led a new informatics organization focused on business partnering and driving technology innovation to address business challenges — to ultimately benefit patients. 

Steve joined Roche in 2008 as Basel Site Head, Pharma Research Informatics. In 2010, he became Global Head of Scientific Information Systems and Principal Architect, Pharma Research and Early Development (pRED) Informatics. Steve was Head of Pharma Informatics for Asia Pacific based in Shanghai and Singapore for three years. He then took on the role of Head of Diagnostics Information Solutions Software Center of Excellence before being appointed Global Head of Informatics. 

Steve is passionate about finding new ways to more effectively bring medical innovation to our patients, particularly where the application of technology can bring about a step change.

Prior to joining Roche, Steve held various IT and management positions at Astra Zeneca in the UK. He has a Master’s degree in Chemistry from The University of St Andrews (UK). 

 

DR. ALLISON GARDNER
Lecturer in Data Science, Programme Director for the Integrated Degree Apprenticeship in Data Science
Keele University
         
 
DR. ALLISON GARDNER
Lecturer in Data Science, Programme Director for the Integrated Degree Apprenticeship in Data Science
Keele University
         
 

Allison lectures at Keele University in Bioinformatics and Data Science and is the Programme Director for the Data Science Degree Apprenticeship. She is a co-founder of Women Leading in AI. Her research is primarily focused on algorithmic bias; gender and computing; AI Ethics and Governance of AI. She works on the IEEE P7000 Global Initiative on the Ethics of Autonomous and Intelligent Systems and the ISO standard on Artificial Intelligence. She speaks internationally on AI Ethics, the need for diversity in tech and the potential regulation and governance of AI. Allison acts as a consultant for a variety of companies on the ethical design of autonomous and intelligent systems and development of algorithmic impact assessments. She is also a district councillor and an alumnus of the first cohort of the Jo Cox Women in Leadership Programme.

ANDREAS CLEVE
Co-Founder and CEO
Corti
         
 
ANDREAS CLEVE
Co-Founder and CEO
Corti
         
 

Andreas Cleve is Corti’s co-founder and CEO. After spending nearly a decade working as a multi-entrepreneur in AI, Andreas founded Corti. Corti uses advanced voice- and pattern recognition technology to assist and augment medical professionals in predicting medical cases in real-time and provides them with intelligent decision support. It allows them to arrive at a conclusion faster and
to provide a better-informed treatment.

Andreas has always been incredibly passionate about the possibilities that AI can provide to the healthcare sector and how we can leverage advanced technology in our most vital industry. While serving as CEO of Corti, he founded Nordic.AI and now sits as chairman of the board. Nordic.AI was created as an anchor for the Nordic machine learning and AI community, it hosts early events and meetups, bringing all the great Scandinavian minds together. Andreas has landed coverage
in print and broadcast outlets all

DR. ROOPA DHATT
Executive Director & Co-Founder
Women in Global Health
         
 
DR. ROOPA DHATT
Executive Director & Co-Founder
Women in Global Health
         
 

Dr Roopa Dhatt is a passionate advocate for gender equality in global health and a leading voice in the movement to correct the gender imbalance in global health leadership. Determined to build a movement to transform women’s leadership opportunities in health, Dr Dhatt co-founded Women in Global Health in 2015.

Today, Women in Global Health has more than 25,000 supporters in more than 90 countries and continues to grow. Dr Dhatt, the Executive Director, and the global team work with a network of WGH chapters in every region to challenge power and privilege for gender equity in health by mobilizing a diverse group of emerging women health leaders, by advocating to existing global health leaders to commit to transform their own institutions, and by holding these leaders to account.  With more than 15 chapters in all regions, Women in Global Health is changing the conversation about women’s leadership in health at global, national and local levels.

Dr Dhatt is particularly committed to addressing issues of power, privilege, and intersectionality that keep many women from global health leadership roles and to opening up spaces for the voices of these women to be heard. Women in Global Health’s flagship Heroines of Health event provides a platform for women from diverse backgrounds to share their stories and to advance their leadership. As Co-Chair of the Gender Equity Hub in the Global Health Workforce Network, Women in Global Health published Delivered by Women, Led by Men which looking collectively for the first time at issues of leadership, decent work free from all forms of discrimination, harassment, including sexual harassment, the gender pay gap, and occupational segregation—across the entire health workforce. In recognition of her work advancing gender equality in health, Dr Dhatt was recognized in the Gender Equality Top 100, the most influential people in global policy 2019.

Dr Dhatt is a regular speaker at global health events and has published her views on gender equality widely, including in the Lancet. Dr Dhatt also serves on several advisory bodies advancing gender equality in health, President Council of PathFinder International, Ambassador for Intelligent Health (AI) Conference, the Strategic Advisory Committee for the Global Health Workforce Network (GHWN), and GlobeMed Advisory Board. She was formerly on the Research in Gender and Ethics (RinGS) Advisory Board, Global Health 50/50 Advisory Council, the Global Health Council Advisory Council, and Women Leaders in Global Health Conference Steering Committee in 2017 and 2018. She has led global campaigns relating to the health Sustainable Development Goals (SDGs), health and climate change, the social determinants of health, and Universal Health Coverage (UHC), engaging people from more than 120 countries.

Dr. MARCO MARSELLA
Head of the Unit - DG CONNECT
European Commission
Dr. MARCO MARSELLA
Head of the Unit - DG CONNECT
European Commission

Marco Marsella is Head of Unit ‘Learning, Multilingualism and Accessibility’ in the Directorate General for Communications Networks, Content and Technology (DG CONNECT) of the European Commission.  

 The unit supports policy, research, innovation and deployment of learning technologies and key enabling digital language technologies and services to allow all European consumers and businesses to fully benefit from the Digital Single Market. The unit is responsible for the Web Accessibility Directive which aims to make public sector websites and mobile applications accessible to people with impairments. The unit also promotes a better internet for children by protecting and empowering children online, and improving the quality of content available to them.

 He has worked on policy development, innovation and research implementation in the areas of digital content, technologies for learning, e-inclusion, assistive technologies and better internet for kids. Prior to joining the European Commission, Marco worked as researcher and AI (artificial intelligence) specialist in Italy.

 

Prof. THOMAS WIEGAND
Executive Director
Fraunhofer HHI
Prof. THOMAS WIEGAND
Executive Director
Fraunhofer HHI

Thomas Wiegand is a professor in the department of Electrical Engineering and Computer Science at the Technical University of Berlin and is jointly heading the Fraunhofer Heinrich Hertz Institute, Berlin, Germany. He received the Dipl.-Ing. degree in Electrical Engineering from the Technical University of Hamburg-Harburg, Germany, in 1995 and the Dr.-Ing. degree from the University of Erlangen-Nuremberg, Germany, in 2000. 

The projects that he co-chaired for the development of the H.264/MPEG-AVC standard have been recognized by an ATAS Primetime Emmy Engineering Award. He was also a recipient of a ATAS Primetime Emmy Engineering Award for the development of H.265/MPEG-HEVC and a pair of NATAS Technology & Engineering Emmy Awards.

AMANDEEP GILL
Project Lead, I-DAIR and Former Executive Director, UNSG High Level Panel on Digital Corporation
United Nations
United Nations
AMANDEEP GILL
Project Lead, I-DAIR and Former Executive Director, UNSG High Level Panel on Digital Corporation
United Nations
United Nations

Amandeep Singh Gill joined the Indian Foreign Service in 1992.

He has served abroad at the Indian Mission to the UN and the Conference on Disarmament in Geneva (1994-1996, 2010-2013), the Indian Embassy in Tehran (2001-2004) and the High Commission of India in Colombo (2004-2006). At headquarters in New Delhi, he has served thrice in the Disarmament and International Security Affairs Division (1998-2001, 2006-2010 and 2013-2016) as well as in the United Nations Division (1996-1998). He served as the Head of the Disarmament and International Security Division in the Ministry of External Affairs from 2013 to 2016. He has also served as an expert on the UN Secretary General’s panels of experts on the Fissile Material Cut-off Treaty (FMCT), Small Arms and Light Weapons and on Missiles. He participated in the UN Disarmament Fellowship programme in 1999.

He is the current Chair of the Group of the Group of Governmental Experts (GGE) of the Convention on Certain Conventional Weapons (CCW) on Lethal Autonomous Weapons Systems (LAWS). He is also President-designate of the 2017 Meeting of States Parties to the Biological and Toxin Weapons Convention (BTWC).
Amandeep Singh Gill has a B. Tech in engineering from Punjab University, Chandigarh and an Advanced Diploma in French History and Language from Geneva University. His PhD from the Department of War Studies at King’s College, London is on Nuclear Learning in Multilateral Forums. During 2008-2009, he was a visiting scholar at Stanford University’s Center for International Security and Cooperation (CISAC) on an Asia Foundation regional security studies fellowship. As a scholar he has contributed to the Bulletin of Atomic Scientists, the Lowy Institute, the East West Institute, the Center for a New American Security and the Indian Economic and Social History Review.

Amandeep Singh Gill was born in 1968 in Chandigarh. He is married to Ashma Singh and has a daughter (Bani) and a son (Ujjay). His personal interests include creative writing, yoga and sustainable agriculture. His first book of poems in English was published by Wisdom Tree in 2016.

NAOMI LEE
Head of Research
The Lancet
NAOMI LEE
Head of Research
The Lancet

Naomi Lee is a Senior Executive Editor at the leading medical journal The Lancet. She has responsibility for research, leading the development and implementation of the research strategy for The Lancet, and advising on the research content of the other journals in The Lancet family of journals. Naomi handles peer review and commissioning across a broad range of subjects including her specialist areas of surgery, digital medicine/AI, and medical technology. She is also a vice chair for the ITU/WHO Focus Group on Artificial Intelligence for Health.

Naomi joined The Lancet in 2014 and was previously the Executive Editor (Digital) where alongside editorial work she led the internal and external digital transformation of The Lancet group. Previously she studied medicine at Cambridge University and King’s College London, before training in surgery, specialising in urology and working for almost 10 years in the United Kingdom. She has completed fellowships in Argentina, and Mexico. She has also studied data science at University College London.

DR. ANURAG AGRAWAL
Director
Institute of Genomics and Integrative Biology at Council of Scientific and Industrial Research
DR. ANURAG AGRAWAL
Director
Institute of Genomics and Integrative Biology at Council of Scientific and Industrial Research

Dr. Anurag Agrawal took charge as director of CSIR Institute of Genomics & Integrative Biology (IGIB) on 25th October 2017. He graduated in medicine from the All India Institute of Medical Sciences in 1994, followed by specialization in Internal Medicine, Pulmonary Disease, and Critical Care from Baylor College of Medicine, Houston, (2003) and a PhD in physiology from Delhi University. After serving as a faculty member of the Department of Medicine at Baylor, he joined IGIB in 2007, where he established the Centre of Excellence for Translational Research in Asthma & Lung disease (TRiAL) and the CSIR program for Effective Application of Community Health efforts through new age Information Technology (EACH-IT). His research activities include use of experimental and computational model-systems to study disease, especially asthma. Dr Agrawal believes health data analytics, with artificial intelligence applications, to be the new frontier of medicine and is actively engaged in promoting the confluence of medicine and informatics. He has more than 100 scientific publications, mostly original research findings communicated in high-impact journals. He has been recognized internationally, as an alumnus of Kavli Frontiers of Science program of the US National Academy of Sciences, as well as nationally in the form of the Shanti Swaroop Bhatnagar award (Medical Sciences, 2014), National Bioscience award (2015), Wellcome Trust DBT India Alliance senior fellowship (2015), Lady Tata Young Researcher Award (2010) and the Swarnjayanti Fellowship of the Department of Science and Technology (2010). Dr. Agrawal is a member and fellow of numerous academic societies and serves on advisory bodies at Public Health Foundation of India, Lady Tata Memorial Trust, Centre for Cellular & Molecular Biology, Centre for Brain Research, and Indraprastha Institute of Information Technology, amongst others, as well as an advisor for start up companies and healthcare organizations.

DR. ERIC OERMANN
Director | AISINAI
Instructor of Neurological Surgery, Department of Neurosurgery | Mount Sinai Health System
DR. ERIC OERMANN
Director | AISINAI
Instructor of Neurological Surgery, Department of Neurosurgery | Mount Sinai Health System

Eric Karl Oermann, M.D. is an Instructor of Neurological Surgery in the Mount Sinai Health System and the Director of AISINAI, Mount Sinai’s artificial intelligence research group. He studied mathematics at Georgetown University with a focus on differential geometry. Prior to attending medical school, Dr. Oermann spent six months with the President’s Council on Bioethics studying human dignity under the mentorship of physician-philosopher Edmund Pellegrino, M.D.. Dr. Oermann has won numerous awards for his scholarship including fellowships from the American Brain Tumor Association and Doris Duke Charitable Research Foundation where he was first exposed to neural networks and deep learning. He has published over eighty manuscripts spanning basic research on machine learning, deep learning, and the philosophy of medicine.

As a resident Dr. Oermann was selected as one of Forbes Magazine’s “30 Under 30” for his work in using machine learning to develop prognostic models for cancer patients. Dr. Oermann completed a postdoctoral fellowship at Google (Google Health / Verily Life Sciences). He is interested in weakly supervised learning, reinforcement learning with imperfect information, and in building artificial neural networks that more accurately model biological neural networks (“machines that think like humans”). As a physician, he is also interested in the application of deep learning to solve a wide range of practical problems in the medical sciences for improving clinical care.

 

LETIZIA GIONFRIDA
CEO & Managing Director
Arthronica
 
LETIZIA GIONFRIDA
CEO & Managing Director
Arthronica
 
DR. JAMES KINROSS
Senior Lecturer and Consultant in Colorectal Surgery
St. Mary's Hospital, Imperial College London
 
DR. JAMES KINROSS
Senior Lecturer and Consultant in Colorectal Surgery
St. Mary's Hospital, Imperial College London
 

Dr. James Kinross is a consultant colorectal surgeon, at St. Mary’s Hospital London. His clinical interests are in minimally invasive and laparoscopic surgery for the treatment of colorectal cancer. He also has an interest in surgical nutrition and modulation of the gut microbiota by pro and prebiotics for improved operative outcomes. He was trained in Northwest London, and he was an NIHR Clinical Lecturer in Surgery and an Ethicon Laparoscopic Fellow in Colorectal Surgery. He was awarded a Royal College of Surgeons of England training fellowship during his PhD and he was funded by the Academy of Medical Sciences as an early stage lecturer. He is a visiting Professor at the Royal College of Surgeons of Ireland. He is currently funded by Bowel and Cancer research and the Imperial BRC. You can follow him on Twitter at @bowelsurgeon. 

 

He performs translational research into computational and systems biology in surgery. Specifically, he is involved in clinical trials using intra-operative mass spectrometry (known as Real-time Electrospray Ionisation Mass Spectrometry or REIMS) for improving precision in the surgical treatment of colorectal cancer. This technology is also known as the iknife, and he is working on both surgical and endoscopic applications. Mass Spectrometry Imaging (MSI) is complimentary to REIMS and provides novel insights into tumour biology and tumour phenotypes. Dr. Kinross’s research is establishing if metabonomic approaches such as these can be used for stratifying the treatment of both early and advanced cancers. 

Dr. Kinross also studies the role of the gut microbiome in the aetiology of colon cancer, Crohn’s disease and obesity. This is because intestinal inflammation is a common pathway across all conditions. He is performing clinical research at Imperial College London and at the Royal Marsden Hospital. The aim is to develop novel biomarkers for the early detection of bowel cancer, and to develop novel therapies for its treatment based on a deeper understanding of how the microbiota that reside in the gut influence tumour biology and the response of cancer to treatment. As part of this I collaborate internationally with researchers in the USA and across Europe.

Finally, he has a separate interest in the educational application of virtual worlds and gaming technologies for surgical and medical education. He works as part of a team that is building next generation, immersive simulators for use in major incidents and trauma training.

 

OLIVER SMITH
Strategy Director & Head of Ethics
Alpha Health, Telefónica Innovación Alpha
OLIVER SMITH
Strategy Director & Head of Ethics
Alpha Health, Telefónica Innovación Alpha

Oliver Smith is the Strategy Director & Head of Ethics at Alpha Health, the health tech Moonshot of Telefónica Innovación Alpha.

 

Oliver propels Alpha Health’s strategy development, establishing and maintaining strong partnerships to further its mission to deliver breakthrough solutions which address the greatest challenges in the healthcare sector worldwide. In addition, Oliver is the Head of Ethics at Alpha Health, ensuring the total trust of users is at the very centre of the Moonshot’s operations.

 

Prior to joining Alpha Health in 2016, Oliver worked as the Director of Strategy and Innovation at Guy’s and St Thomas’ Charity, Deputy Director of Health and Wellbeing at the Department of Health and as a Policy Advisor to the Prime Minister’s Strategy Unit.

 

DR. AMRITA KUMAR
Consultant Radiologist & AI Clinical Lead
Frimley Health NHS Foundation Trust
DR. AMRITA KUMAR
Consultant Radiologist & AI Clinical Lead
Frimley Health NHS Foundation Trust

Dr. Amrita Kumar is a Consultant Radiologist at Frimley Health NHS Foundation Trust, with a sub-specialist interest in breast cancer screening. She is leading trust wide research collaboration to implement novel artificial intelligence software for improved patient outcomes. She has been appointed as AI Clinical Lead and is responsible for implementation and adoption of Artificial Intelligence practice within the Trust, working in conjunction with various stakeholders with a mission statement of patient-focused value-based healthcare.

VICTORIA MACDONALD
Health and Social Care Editor
Channel 4 News
         
 
VICTORIA MACDONALD
Health and Social Care Editor
Channel 4 News
         
 

Victoria Macdonald is an award-winning journalist, who has been covering health and social care issues for Channel 4 News since 1999.

She reports on changes in the NHS – the reforms and the politics – whether it is in hospitals or in the community or, indeed in Westminster.

She closely follows the care system and how it impacts on the elderly and those with disabilities as well as investigating issues, including mental health, HIV/Aids and TB, and child health.

Victoria is originally from New Zealand and worked for the Sunday Telegraph before joining Channel 4 News.

NEIL SEBIRE
Chief Research Information Officer
Great Ormond Street Hospital
         
 
NEIL SEBIRE
Chief Research Information Officer
Great Ormond Street Hospital
         
 
DR. SUJOY KAR
Chief Medical Information Officer & Vice President
Apollo Hospitals
         
 
DR. SUJOY KAR
Chief Medical Information Officer & Vice President
Apollo Hospitals
         
 

Dr Sujoy Kar is the Chief Medical Information Officer & Vice President at Apollo Hospitals. Previously, he was the Director Medical Services at Apollo Gleneagles Hospitals Kolkata. He obtained his post graduate MD in Clinical Microbiology & Infectious Diseases and is an alumnus of MIT Sloan School of Management. He is a Certified Six Sigma Master Black Belt (Indian Statistical Institute) and member of professional organisations like ACHE, VRARA (Member – Healthcare Sub Committee), CHIME, Harvard Square (LE), ICMR – CIBioD (Member Task Force) and World Economic Forum – Chatbot & AI in Healthcare.

Dr Sujoy is currently associated with IIT Kharagpur & IIM Calcutta as Adjunct Faculty for Healthcare Analytics and Management. He has led teams in multiple award winning Patient Safety & Process Improvement projects. His current and ongoing research interests are in adoption of Artificial Intelligence & Blockchain Technology in Healthcare, Time Driven Activity Based Costing, Living Labs, Digital Health Platforms and Design Thinking in Healthcare.

SUE PAISH
CEO
Canada’s Digital Technology Supercluster
         
 
SUE PAISH
CEO
Canada’s Digital Technology Supercluster
         
 

Sue is the CEO of Canada’s Digital Supercluster where organizations from across
Canada come together to solve some of society’s and industry’s biggest problems.
Bringing together industry, researchers and government partners, the Supercluster
drives the development, deployment and scaling of Canadian made digital technologies
while helping small companies scale, large organizations nimbly deploy digital solutions
and researchers bridge the gap to commercialization. The Supercluster is: speeding up
cancer diagnosis times so that patients get diagnoses in days rather than months,
protecting fresh-water lakes, rivers and streams through a data platform that measures
and manages these precious resources, and using data to predict extreme weather
events. These are just a few of the over 60 projects deployed in the past two years.
Prior to the Supercluster, Sue led organizations through material change. While
Managing Partner of Fasken, the firm grew from one office to nine offices on three
continents, while CEO of Pharmasave, the organization pioneered industry leading
technologies for online medication management, and while CEO of LifeLabs, Sue led
material growth while introducing online access to test results and pre-natal genetic
testing. With the Supercluster, Sue continues to drive business growth and Canada’s
global competitiveness through the Supercluster’s collaborative innovation model,
creating digital solutions better than any single organization could develop on its own.
Sue also is the Chair of the Board of CORIX Group of Companies, and Canexia Health
(previously Contextual Genomics), past Chair of the Business Council of British
Columbia and a Director on the Board of Own the Podium. She is a member of the
Advisory Board for Stemcell Technologies, the Expert Panel on Housing Supply and
Affordability and the Government of Canada’s COVID 19 Supply Council.
Sue’s most cherished moments are those spent exploring BC’s remarkable remote
wilderness with her husband, three daughters and her granddaughter.

DR. ALAIN DAGHER
Neurologist and Professor
Montreal Neurological Institute, McGill University
DR. ALAIN DAGHER
Neurologist and Professor
Montreal Neurological Institute, McGill University

Dr. Dagher is an M.D./Ph.D. who studied Electrical Engineering and Medicine. He is a Neurologist and Professor at McGill University in Montreal (clinician and scientist). His research aims to understand brain reward systems and their role in neurological and psychiatric illness.

 

He uses brain imaging, notably functional magnetic resonance imaging (fMRI), to map brain activity in response to drugs or natural rewards like food and music. He is particularly interested in figuring out what in the brain makes individuals vulnerable to mental illness. He splits his professional life between clinical neurology and research and teaching. He sees people with Parkinson’s Disease in his clinic once a week. Dr. Dagher teaches medical students and Ph.D. students in neuroscience.

DR. INDRA JOSHI
Director of AI
NHSX
DR. INDRA JOSHI
Director of AI
NHSX

Dr Indra Joshi is the acting Director of AI for NHSX, leading on the creation of the NHS AI Lab. Her other responsibilities include overseeing digital health initiatives within the NHS with a focus on data, digital health standards and evidence.

Indra has a unique portfolio with experience stretching across policy, digital health, national project strategy and implementation; whilst remaining true to her professional training as an emergency medic.

She is a Founding Member of One HealthTech – a network which campaigns for the need and importance of better inclusion of all backgrounds, skill sets and disciplines in health technology. Alongside she is a Vice-Chair for the British Computer Society (Health), an international speaker and consultant on digital health, an expedition medic, and most importantly a mum to two wonderful little munchkins.

Dr. ANDREA SUPERTI-FURGA
Head of Genetic Medicine
Lausanne University Hospital
Dr. ANDREA SUPERTI-FURGA
Head of Genetic Medicine
Lausanne University Hospital

Andrea Superti-Furga has obtained his medical degrees at the Universities of Genoa and Zurich and certification in Paediatrics in Italy and Switzerland. His mentors were Professors Paolo Durand, Victor McKusick, Andrea Prader, Andres Giedion, Richard Gitzelmann, Beat Steinmann and Sergio Fanconi.

He developed a research activity on inborn diseases in Zurich and then in New York with Prof. Francesco Ramirez. In 2002, he was appointed Professor for Molecular Pediatrics at the University of Lausanne; in 2004, Chairman of the Department of Paediatrics at the University of Freiburg, Germany; in October 2010 he was awarded the Leenaards Chair of Excellence in Paediatrics at the University of Lausanne. In 2014 and 2015 he was Director of the Department of Paediatrics in Lausanne. Since 2016 he is Professor and Head of the Division of Genetic Medicine at the University Hospital in Lausanne, Switzerland, that includes a clinical section as well as a diagnostic laboratory for cytogenetics and molecular genetics.

His clinical expertise is in paediatrics and genetics. His research activities have been focussed mainly on genetic disorders affecting metabolism, connective tissue, and the skeleton. His skills range from clinical assessment and evaluation to biochemistry, metabolism, molecular biology, next-generation sequencing, bioinformatics, and artificial intelligence.

Andrea Superti-Furga is committed to a holistic approach to children and adults with genetic disorders and rare diseases with a comprehensive perspective that includes the genetic and molecular bases of development and disease, the precision medicine approach to diagnosis and treatment, and the medical, social, economical and ethical issues around individuals with genetic diseases and their families.

Dr. OZANAN MEIRELES
Director of the Surgical Artificial Intelligence and Innovation Laboratory | Massachusetts General Hospital 
Assistant Professor of Surgery | Harvard Medical School
Dr. OZANAN MEIRELES
Director of the Surgical Artificial Intelligence and Innovation Laboratory | Massachusetts General Hospital 
Assistant Professor of Surgery | Harvard Medical School
DR. ROSHANA MEHDIAN
Registrar Trauma and Orhopaedic Surgeon and Director
Hardian Health
       
DR. ROSHANA MEHDIAN
Registrar Trauma and Orhopaedic Surgeon and Director
Hardian Health
       

Interested in speaking at the event?

Please nominate yourself via the form below

Become a speaker